Quality of life profiles and changes in the course of maintenance treatment among 1,015 patients with severe opioid dependence

Substance Use and Misuse

Volumn 46, Issue 6, 2011, Pages 705-715

  Karow, A ^a   Verthein, U ^a   Pukrop, R ^b   Reimer, J ^a   Haasen, C ^a   Krausz, M ^c   Schafer I ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

drug abuse; heroin; heroin assisted treatment; MSQoL; opiate addiction; opioid dependence; quality of life

Indexed keywords

DIAMORPHINE; METHADONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEALTH STATUS; HOSPITALIZATION; HUMAN; MAJOR DEPRESSION; MALE; MULTICENTER STUDY; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SUBSTANCE ABUSE;

ADULT; DEPRESSIVE DISORDER, MAJOR; FEMALE; HEALTH STATUS; HEROIN; HUMANS; MALE; METHADONE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 79953897558     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2010.509854     Document Type: Article

References (46)

1. Alonso, J., Ferrer, M., Gandek, B., Ware, J. E., Jr., Aaronson, N. K.,Mosconi, P., et al. (2004). Health-related quality of life associated with chronic conditions in eight countries: Results from the International Quality of Life Assessment (IQOLA) Project. Quality of Life Research, 13, 283-298. (Pubitemid 38392257)
2. Astals, M., Domingo-Salvany, A., Buenaventura, C. C., Tato, J., Vazquez, J. M., Martin-Santos, R., et al. (2008). Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment. Substance Use & Misuse, 43, 612-632. (Pubitemid 351507738)
3. Batki, S. L., Canfield, K. M., Smyth, E., & Ploutz-Snyder, R. (2009). Health-related quality of life in methadone maintenance patients with untreated hepatitis C virus infection. Drug and Alcohol Dependence, 101, 176-182.
4. Bizzarri, J., Rucci, P., Vallotta, A., Girelli, M., Scandolari, A., Zerbetto, E., et al. (2005). Dual diagnosis and quality of life in patients in treatment for opioid dependence. Substance Use&Misuse, 40, 1765-1776. (Pubitemid 41546463)
5. Brogly, S., Mercier, C., Bruneau, J., Palepu, A., & Franco, E. (2003). Towards more effective public health programming for injection drug users: Development and evaluation of the injection drug user quality of life scale. Substance Use & Misuse, 38, 965-992. (Pubitemid 36665932)
6. Bullinger, M. (2002). Assessing health related quality of life in medicine: An overview over concepts, methods and applications in international research. Restorative Neurology and Neuroscience, 20, 93-101. (Pubitemid 35404343)
7. Cohen, J. (1988). Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Earlbaum Associates.
8. Darke, S., Hall,W.,Wodak, A., Heather, N., & Ward, J. (1992). Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: The Opiate Treatment Index. British Journal of Addiction, 87, 733-742.
9. Darke, S., Ward, J., Zador, D., & Swift, G. (1991). A scale for estimating the health status of opioid users. British Journal of Addiction, 86, 1317-1322.
10. Derogatis, L. R. (1983). SCL-90-R: Administration, scoring and procedures.Manual II. Towsen,MD: Clinical Psychometric Research.
11. Derogatis, L. R., Rickels, K., & Rock, A. F. (1976). The SCL-90 and the MMPI: A step in the validation of a new self-report scale. British Journal of Psychiatry, 128, 280-289.
12. Eklund, C., Melin, L., Hiltunen, A., & Borg, S. (1994). Detoxification from methadone maintenance treatment in Sweden: Longterm outcome and effects on quality of life and life situation. International Journal of Addiction, 29, 627-645. (Pubitemid 24125645)
13. Giacomuzzi, S. M., Riemer, Y., Kemmler, G., Ertl, M., Richter, R., Rossler, H., et al. (2001). Subjective wellbeing and somatic markers in methadone substitution: Evaluation of 61 heroin addicts. Fortschritte Medizin, 119, 103-108.
14. Gsellhofer, B., & Fahrner, E.M. (1994). European Addiction Severity Index EuropASI. Manual für Training und Durchführung von Interviews mit dem EuropASI. In IFT Institut für Therapieforschung: München.
15. Haasen, C., Verthein, U., Degkwitz, P., Berger, J., Krausz, M., & Naber, D. (2007). Heroin-assisted treatment for opioid dependence: Randomised controlled trial. British Journal of Psychiatry, 191, 55-62. (Pubitemid 47035182)
16. Karow, A., Schafer, I., Hirdes, F., Osterwald, C., & Naber, D. (2008a). Subjective view of positive symptoms and quality of life in patients with schizophrenia. Psychiatrische Praxis, 35, 286-293.
17. Karow, A., Verthein, U., Krausz, M., & Schafer, I. (2008b). Association of personality disorders, family conflicts and treatment with quality of life in opiate addiction. European Addiction Research, 14, 38-46.
18. Kastelic, A., Dubajic, G., & Strbad, E. (2008). Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression. Addiction, 103, 1837-1846.
19. Katschnig, H. (2006). Quality of life in mental disorders: Challenges for research and clinical practice. World Psychiatry, 5, 139-145.
20. Katschnig, H., Angermeyer, M. C., Katschnig, H., Freeman, H., & Sartorius, N. (2005). Quality of life in depression. In Katschnig, H. and Angermeyer, M. C., Ed.: Katschnig, H., Freeman, H. and Sartorius, N. Quality of life in mental disorders (pp. 3-17). Chicester: Wiley.
21. Kennedy, S. H., Eisfeld, B. S., & Cooke, R. G. (2001). Quality of life: An important dimension in assessing the treatment of depression? Journal of Psychiatry and Neuroscience, 26(Suppl), 23-28.
22. Kleinig, J., & Einstein, S. (2006). Ethical challenges for intervening in drug use: Policy. Huntsville, TX: Research and Treatment Issues OICJ.
23. Kokkevi, A., & Hartgers, C. (1995). EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. European Addiction Research, 1(4), 208-210.
24. Laudet, A. B., Becker, J. B., & White, W. L. (2009). Don't wanna go through that madness no more: Quality of life satisfaction as predictor of sustained remission from illicit drug misuse. Substance Use & Misuse, 44, 227-252.
25. Maremmani, I., Pani, P. P., Pacini, M., Perugi, G. (2007). Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients. Journal of Substance Abuse Treatment, 33, 91-98. (Pubitemid 350198612)
26. McGahan, P. L., Parente, J. A., Parente, R., & McLellan, A. T. (1986). Addiction severity index: Composite scores manual. Pennsylvania: Veterano Administration Press.
27. McHorney, C. A., Ware, J. E., & Raczek, A. E. (1993). The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care, 31(3), 247-263.
28. Miller, P. G., & Miller, W. R. (2009). What should we be aiming for in the treatment of addiction? Addiction, 104, 685-686.
29. Millson, P. E., Challacombe, L.,Villeneuve, P. J., Fischer, B., Strike, C. J., Myers, T., et al. (2004). Self-perceived health among Canadian opiate users: A comparison to the general population and to other chronic disease populations. Canadian Journal of Public Health, 95, 99-103. (Pubitemid 38578668)
30. Perneger, T. V., Giner, F., del Rio, M., & Mino, A. (1998). Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. British Medical Journal, 317, 13-18. (Pubitemid 28333818)
31. Ponizovsky, A. M., & Grinshpoon, A. (2007). Quality of life among heroin users on buprenorphine versus methadone maintenance. American Journal of Drug and Alcohol Abuse, 33, 631-642. (Pubitemid 47463774)
32. Ponizovsky, A. M., Margolis, A., Heled, L., Rosca, P., Radomislensky, I., & Grinshpoon, A. (2010). Improved quality of life, clinical, and psychosocial outcomes among heroin-dependent patients on ambulatory buprenorphine maintenance. Substance Use & Misuse, 45(1-2), 288-313.
33. Prince, P. N., & Prince, C. R. (2001). Subjective quality of life in the evaluation of programs for people with serious and persistent mental illness. Clinical Psychology Review, 21, 1005-1036. (Pubitemid 32846588)
34. Pukrop, R., Moller, H. J., & Steinmeyer, E. M. (2000). Quality of life in psychiatry: A systematic contribution to construct validation and the development of the integrative assessment tool "modular system for quality of life." European Archives of Psychiatry and Clinical Neuroscience, 250, 120-132. (Pubitemid 30417210)
35. Pukrop, R., Schlaak, V., Moller-Leimkuhler, A. M., Albus, M., Czernik, A., Klosterkotter, J., et al. (2003). Reliability and validity of quality of life assessed by the short-form 36 and the modular system for quality of life in patients with schizophrenia and patients with depression. Psychiatry Research, 119, 63-79. (Pubitemid 36829419)
36. Richter, D., Eikelmann, B., & Berger, K. (2004). Use of the SF-36 in the evaluation of a drug detoxification program. Quality of Life Research, 13, 907-914. (Pubitemid 39005100)
37. Ruhrmann, S., Paruch, J., Bechdolf, A., Pukrop, R., Wagner, M., Berning, J., et al. (2008). Reduced subjective quality of life in persons at risk for psychosis. Acta Psychiatrica Scandinavica, 117, 357-368. (Pubitemid 351502436)
38. Schäfer, A., Wittchen, H. U., Backmund, M., Soyka, M., Golz, J., Siegert, J., et al. (2009). Psychopathological changes and quality of life in hepatitis C virus-infected, opioid-dependent patients during maintenance therapy. Addiction, 104, 630-640.
39. Scheurich, A.,Muller, M. J.,Wetzel, H., Anghelescu, I., Klawe, C., Ruppe, A., et al. (2000). Reliability and validity of the German version of the European Addiction Severity Index (EuropASI). Journal of Studies on Alcohol, 61, 916-919.
40. Schwartz, R. P., Brooner, R. K., Montoya, I. D., Currens, M., & Hayes, M. (1999). A 12-year follow-up of a methadone medical maintenance program. American Journal of Addiction, 8, 293-299.
41. Torrens, M., Domingo-Salvany, A., Alonso, J., Castillo, C., & San, L. (1999). Methadone and quality of life. Lancet, 353, 1101.
42. Ventegodt, S., & Merrick, J. (2003). Psychoactive drugs and quality of life. Scientific World Journal, 3, 694-706.
43. Verthein, U., Degkwitz, P., Haasen, C., & Krausz, M. (2005). Significance of comorbidity for the long-term course of opiate dependence. European Addiction Research, 11, 15-21. (Pubitemid 40082206)
44. Ware, J. E., & Gandek, B. (1998). Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. Journal of Clinical Epidemiology, 51, 903-912. (Pubitemid 28527145)
45. Wasserman, D. A., Sorensen, J. L., Delucchi, K. L., Masson, C. L., & Hall, S. M. (2006). Psychometric evaluation of the Quality of Life Interview, Brief Version, in injection drug users. Psychology of Addictive Behaviors, 20(3), 316-321. (Pubitemid 44386429)
46. World Health Organization. (1993). The ICD-10 classification of mental and behavioural disorders: Diagnostic criteria for research. WHO.